GPCR screening and drug discovery: Challenges and latest trends

European Pharmaceutical Review

Volumn 17, Issue 2, 2012, Pages

  Martins, Sofia M A ^a   Trabuco, João R G ^a   Monteiro, Gabriel A ^a   Prazeres, Duarte Miguel ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CLATHRIN; DYNAMIN; G PROTEIN COUPLED RECEPTOR;

ARTICLE; DRUG DEVELOPMENT; DRUG MARKETING; HIGH THROUGHPUT SCREENING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TREND STUDY;

EID: 84876329052     PISSN: 13608606     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (31)

1. Prazeres, D.M.F., et al. Towards a high-throughput drug discovery platform for the screening of GPCR targets in cells, in 1st Portuguese Meeting in Bioengineering (ENBENG), 2011
2. Schlyer, S. and R. Horuk, I want a new drug: G-proteincoupled receptors in drug development. Drug Discov Today, 2006. 11(11-12): p. 481-93
3. Sullivan, F., Emerging technologies in GPCR-based drug target receptors. Frost & Sullivan Annual Report, 2009
4. Lefkowitz, R.J., Seven transmembrane receptors: something old, something new. Acta Physiologica, 2007. 190(1): p. 9-19
5. Cabrera-Vera, T.M., et al., Insights into G protein structure, function, and regulation. Endocr Rev, 2003. 24(6): p. 765-81
6. Hendriks-Balk, M.C., et al., Regulation of G proteincoupled receptor signalling: focus on the cardiovascular system and regulator of G protein signalling proteins. Eur J Pharmacol, 2008. 585(2-3): p. 278-91
7. Lagerstrom, M.C. and H.B. Schioth, Structural diversity of G protein-coupled receptors and significance for drug discovery. Nature Reviews Drug Discovery, 2008. 7(4): p. 339-57
8. Kristiansen, K., Molecular mechanisms of ligand binding, signalling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther, 2004. 103(1): p. 21-80
9. Moore, C.A.C., S.K. Milano, and J.L. Benovic, Regulation of receptor trafficking by GRKs and arrestins. Annual Review of Physiology, 2007. 69: p. 451-482
10. Shenoy, S.K. and R.J. Lefkowitz, Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination. Journal of Biological Chemistry, 2003. 278(16): p. 14498-14506
11. Brink, C.B., et al., Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology. Br J Clin Pharmacol, 2004. 57(4): p. 373-87
12. Jacob, L, et al., Virtual screening of GPCRs: an in silico chemogenomics approach. BMC Bioinformatics, 2008. 9: p. 363
13. Schlyer, S. and R. Horuk, I want a new drug: G-proteincoupled receptors in drug development. Drug Discovery Today, 2006. 11(11-12): p. 481-493
14. Sewing, A. and D. Cawkill, High-throughput lead finding and optimisation for GPCR targets. GPCRs: From Deorphanization to Lead Structure Identification, 2007. 2: p. 249-267
15. Greasley, P.J. and F.P. Jansen, G-protein-coupled receptor screening technologies. Drug Discovery Today: Technologies, 2005. 2(2): p. 163-170
16. Heilker, R., et al., G-protein-coupled receptor-focused drug discovery using a target class platform approach. Drug Discovery Today, 2009. 14(5-6): p. 231-240
17. Thomsen, W., J. Frazer, and D. Unett, Functional assays for screening GPCR targets. Current Opinion in Biotechnology, 2005. 16(6): p. 655-665
18. Wunder, F., et al., Functional cell-based assays in microliter volumes for ultra-high throughput screening. Combinatorial Chemistry & High Throughput Screening, 2008. 11(7): p. 495-504
19. Eglen, R.M., Functional G protein-coupled receptor assays for primary and secondary screening. Combinatorial Chemistry & High Throughput Screening, 2005. 8(4): p. 311-318
20. Degorce, F., et al., HTRF: A technology tailored for drug discovery - a review of theoretical aspects and recent applications. Curr Chem Genomics, 2009. 3: p. 22-32
21. Marshall IC, Owen DE, and M. S., Measuring Ca2+ changes in multiwell format using the fluorometric imaging plate reader. Methods in Molecular Biology, 2006. 312: p. 125-131
22. Hodder, P., et al., Miniaturization of intracellular calcium functional assays to 1536-well plate format using a fluorometric imaging plate reader. Journal of Biomolecular Screening, 2004. 9(5): p. 417-426
23. Ungrin, M.D., et al., An automated aequorin luminescence-based functional calcium assay for Gprotein-coupled receptors. Analytical Biochemistry, 1999. 272(1): p. 34-42
24. Ross, D.A., et al., Multiplexed assays by high-content imaging for assessment of GPCR activity. Journal of Biomolecular Screening, 2008. 13(6): p. 449-455
25. Kostenis, E., M. Waelbroeck, and G. Milligan, Techniques: Promiscuous G alpha proteins in basic research and drug discovery. Trends in Pharmacological Sciences, 2005. 26(11): p. 595-602
26. Breitwieser, G.E., G Protein-Coupled Receptor Oligomerization. Circulation Research, 2004. 94(1): p. 17-27
27. Kenakin, T. and L.J. Miller, Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev, 2010. 62(2): p. 265-304
28. Femandes, T.G., et al., 3D cell culture microarray for high-throughput studies of stem cell fate. Abstracts of Papers of the American Chemical Society, 2011. 241
29. Chen, P.-C., Y.-Y. Huang, and J.-L. Juang, MEMS microwell and microcolumn arrays: no\el methods for high-throughput cell-based assays. Lab on a Chip, 2011. 11(21): p. 3619-3625
30. Fang, Y., A.G. Frutos, and R. Verklereen, Label-free cellbased assays for GPCR screening. Combinatorial Chemistry & High "Throughput Screening, 2008. 11(5): p. 357-369
31. Wu, M.-H., S.-B. Huang, and G.-B. Lee, Microfluidic cell culture systems for drug research. Lab on a Chip, 2010. 10(8): p. 939-956